Topic summary

Comparing prices across jurisdictions without misleading yourself

Access › Pricing compounding data table cost per milligram Solved Wiki

This is a generated summary. It shows the 9 most-liked posts from a topic of 84, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

t.pereiraTL2 Moderator Solution25 May 2026#4

f.villalobos, post #3: On the opening post — agreed on the reasoning, with one qualification. Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be compared on price per milligram alone because dead volume, wastage, and number of doses actually… Go to post

Community wiki post. Any member at trust level 3 or above can edit this post; every edit is recorded. Last edited by revision_history on 8 Jul 2026.

8 Jul 2026 — revision_history: Restructured into sections so the outline is navigable.

Editors: KTurkington, y.mensah, chromatogram, revision_history

Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented failure of cheaper alternatives.

9 likes in reply to #3 2mo

n.kuuselaTL2 Moderator26 May 2026#6

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

29 likes 2mo

baseline_peakTL2Member1 Jun 2026#26

Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.

30 likes 2mo

e.ndiayeTL2 Moderator3 Jun 2026#34

I read post #32 twice before replying, because I had assumed the opposite.

List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially. List price is not what anyone pays.

32 likes 2mo

baseline_tableTL2Member6 Jun 2026 · edited#46

Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented failure of cheaper alternatives.

33 likes 2mo

bench_entryTL3Regular8 Jun 2026#54

e.pires, post #13: post #12 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this,… Go to post

Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented failure of cheaper alternatives.

26 likes in reply to #13 2mo

j.mwangiTL4 Moderator11 Jun 2026#64

post #63 is right about the mechanism and I think understates the practical bit.

Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some proteins; incretin agonist pricing might follow.

29 likes 2mo

y.ibarraTL2 Moderator12 Jun 2026 · edited#69

d.eriksen, post #63: Worth separating two things that post #59 runs together. Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing matters. Go to post

Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers and manufacturers.

28 likes in reply to #63 2mo

diluent_watchTL2Member13 Jun 2026#75

PharmNotes_Whitfield, post #7: Worth separating two things that post #3 runs together. International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US prices are higher than other developed nations. Go to post

Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented failure of cheaper alternatives.

30 likes in reply to #7 1mo

Read the full topic (84 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
Manufacturer assistance programmes and their eligibility rules Access › Pricing formulary data table compounding On the subject in the title: Manufacturer assistance programmes and their eligibility rules Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…	+37	42	32k	11d
Cost per delivered dose, which is the number that matters Access › Pricing cost per milligram data table compounding formulary Solved Cost per delivered dose, which is the number that matters — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what…	+54	59	30k	4mo
Pen wastage and its effect on real cost — the long version Access › Pricing formulary data table cost per milligram compounding Posting this under the heading it deserves: Pen wastage and its effect on real cost — the long version Everything below is what sits behind that. Documenting an access outcome, dated, because everything in…		2	34k	13mo
Coming back to: Cost per delivered dose, which is the number that matters Access › Pricing formulary data table compounding cost per milligram Under review On the subject in the title: Cost per delivered dose, which is the number that matters Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…	+6	10	2.5k	19mo
[2026 update] Comparing prices across jurisdictions without misleading yourself Access › Pricing formulary compounding data table On the subject in the title: Comparing prices across jurisdictions without misleading yourself Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…		2	809	23h

Related topics — sharing the tags compounding, data table, cost per milligram

Topic	Participants	Replies	Views	Activity
Coming back to: Oxidation pathways for methionine and tryptophan Analytics › Impurities & related substances HPLC counter-ion content water content data table Oxidation pathways for methionine and tryptophan Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…	+1	5	36k	15mo
NHS criteria and how they are applied in practice Regional › UK & Ireland NHS cost per milligram personal import MHRA NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines…	+37	42	31k	2d
EU-wide position versus national implementation — what changed since Regional › European Union EMA cost per milligram personal import formulary Pinned EU-wide position versus national implementation — what changed since Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included,…	+22	26	58k	2mo
Follow-up: UK access routes, dated and sourced Regional › UK & Ireland personal import cost per milligram MHRA Solved On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of May 2026, in…	+10	14	27k	2d
A rising related-substance total over six months: degradation or method drift? Analytics › Impurities & related substances data table endotoxin testing HPLC Closed Asking directly, because I could not find a straight answer: A rising related-substance total over six months: degradation or method drift? Posting the method first, because I know what the first three…	+37	42	37k	23mo